Ilya Pharma presented at the Redeye unlisted event December 2
News
FDA open to new endpoints for patients with difficult wounds
FDA opened for 5 new endpoints in Nov 2020 (vs. only 1 until then) following thorough work by FDA’s Inter-center Wound Healing Work group and industry Wound Experts/FDA Clinical Endpoints Project.
Meet Ingemar Kihlstörm - facilitating the next stage of growth
Financing innovations in pharmaceutical development – facilitating the next stage of growth
Operational Report Q3 2020
Some thoughts from the CEO
Operational Report Q2 2020
High level operational report summarising key milestones Q2 2020 and forward looking statement.
Ilya Pharma awarded Euros 5.3 million from EIC Accelerator to fast track Phase II study of first-in-class ILPI100 advanced therapy for wound treatment in people with diabetes
4000 applicants, 72 SMEs awarded, Ilya Pharmas project among the 1.8 % winners!